2023
DOI: 10.1016/j.foodchem.2022.134685
|View full text |Cite
|
Sign up to set email alerts
|

Recent advances in delivery systems of fucoxanthin

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
3
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 9 publications
(6 citation statements)
references
References 86 publications
0
3
0
Order By: Relevance
“…Moreover, Lykov et al [ 129 ] demonstrated no toxicity of a composition of fucoxanthin with particles of porous aluminum oxide with polydimethylsiloxane on mice splenocytes and thymocytes, both under short-term (24 h) and long-term (129 h) incubation. For more information on the pharmaco/toxicological profile of fucoxanthin and its delivery strategies, several recent reviews are available [ 119 , 130 , 131 , 132 , 133 ].…”
Section: Secondary Metabolitesmentioning
confidence: 99%
“…Moreover, Lykov et al [ 129 ] demonstrated no toxicity of a composition of fucoxanthin with particles of porous aluminum oxide with polydimethylsiloxane on mice splenocytes and thymocytes, both under short-term (24 h) and long-term (129 h) incubation. For more information on the pharmaco/toxicological profile of fucoxanthin and its delivery strategies, several recent reviews are available [ 119 , 130 , 131 , 132 , 133 ].…”
Section: Secondary Metabolitesmentioning
confidence: 99%
“…57,58 Furthermore, the low bioaccessibility of fucoxanthin can be addressed by encapsulation with biopolymers or nanoparticles, including maltodextrin, gum arabic, and caseinate-stabilized zein particles, which not only enhance the thermal stability of fucoxanthin but also improve its intestinal absorption. 59,60 Thus, by further optimizing the chemical structure of fucoxanthin and refining formulation processes, fucoxanthin holds the potential for more extensive clinical trials in treating metabolic diseases.…”
Section: Discussionmentioning
confidence: 99%
“…Consequently, diverse strategies have been developed to improve its absorption and stability. Fucoxanthin’s absorption rate can be increased by utilizing media with high solubility, such as fish oil, medium-chain triacylglycerols, oleic acid, and bovine serum albumin. , Furthermore, the low bioaccessibility of fucoxanthin can be addressed by encapsulation with biopolymers or nanoparticles, including maltodextrin, gum arabic, and caseinate-stabilized zein particles, which not only enhance the thermal stability of fucoxanthin but also improve its intestinal absorption. , Thus, by further optimizing the chemical structure of fucoxanthin and refining formulation processes, fucoxanthin holds the potential for more extensive clinical trials in treating metabolic diseases.…”
Section: Discussionmentioning
confidence: 99%
“…Heatmap analysis showed that some lipids were significantly upregulated in the Low/CK group, but most lipids were significantly downregulated in the High/CK group. Research showed that fucoxanthin exhibits effective resistance to external stress, ensuring normal cell growth and development, and it exerts a physiological effect on optimizing plant growth, development, and immunity [49]. In root tissues, fucoxanthin was upregulated 4.37-fold in the Low/CK group and downregulated 0.82-fold in the High/CK group.…”
Section: Discussionmentioning
confidence: 99%